P2Y(12) Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease

Shunt thrombosis remains a major cause of morbidity and mortality, especially during the initial palliation for single-ventricle physiology. The authors present evidence that the P2Y(12) inhibitor cangrelor may fill a therapeutic void in thromboprophylaxis. They base this theory on results showing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaza, Elisabeth A., Egalka, Matthew C., Zhou, Hairu, Chen, Jianchun, Evans, Denise, Prats, Jayne, Li, Ruizhi, Diamond, Scott L., Vincent, Julie A., Bacha, Emile A., Diacovo, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646421/
https://www.ncbi.nlm.nih.gov/pubmed/29057376
http://dx.doi.org/10.1016/j.jacbts.2017.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646421/
https://www.ncbi.nlm.nih.gov/pubmed/29057376
http://dx.doi.org/10.1016/j.jacbts.2017.04.002

Ejemplares similares